Literature DB >> 16408378

Trastuzumab for early breast cancer: evolution or revolution?

Peter Littlejohns1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16408378     DOI: 10.1016/s1470-2045(05)70533-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

Review 1.  CNS complications of breast cancer: current and emerging treatment options.

Authors:  Evert C A Kaal; Charles J Vecht
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  Cancer in older patients: an analysis of elderly oncology.

Authors:  V Swaminathan; Ra Audisio
Journal:  Ecancermedicalscience       Date:  2012-02-02

3.  More than 9 years of continuous trastuzumab treatment in metastatic breast cancer without cardiac toxicity: a case report and literature review.

Authors:  Florin Badulescu; Adriana Badulescu; Doru Paul; Carmen Florina Popescu; Cristina Florescu
Journal:  Onco Targets Ther       Date:  2014-10-17       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.